4//SEC Filing
Yates Robert Clifton 4
Accession 0001209191-21-049758
CIK 0001828443other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 6:29 PM ET
Size
12.9 KB
Accession
0001209191-21-049758
Insider Transaction Report
Form 4
Yates Robert Clifton
Director
Transactions
- Sale
Ordinary Shares, $0.00001 par value
2021-08-03$21.59/sh−176,149$3,803,110→ 145,242 total - Sale
Ordinary Shares, $0.00001 par value
2021-08-04$21.79/sh−140,042$3,051,515→ 5,200 total - Exercise/Conversion
Ordinary Shares, $0.00001 par value
2021-08-02$6.28/sh+23,062$144,829→ 346,942 total - Sale
Ordinary Shares, $0.00001 par value
2021-08-02$22.06/sh−25,551$563,640→ 321,391 total - Exercise/Conversion
Stock Option
2021-08-02−23,062→ 1,025,225 totalExercise: $6.28Exp: 2024-10-22→ Ordinary Shares, $0.00001 par value (23,062 underlying)
Footnotes (6)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.
- [F3]Represents the weighted average sales price for the price increments ranging from $21.65 to $22.51.
- [F4]Represents the weighted average sales price for the price increments ranging from $21.18 to $21.94.
- [F5]Represents the weighted average sales price for the price increments ranging from $21.51 to $21.92.
- [F6]The stock option is fully vested and exercisable.
Documents
Issuer
Ortho Clinical Diagnostics Holdings plc
CIK 0001828443
Entity typeother
Related Parties
1- filerCIK 0001841149
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 6:29 PM ET
- Size
- 12.9 KB